IL159876A0 - Controlled drug delivery systems providing variable release rates - Google Patents

Controlled drug delivery systems providing variable release rates

Info

Publication number
IL159876A0
IL159876A0 IL15987602A IL15987602A IL159876A0 IL 159876 A0 IL159876 A0 IL 159876A0 IL 15987602 A IL15987602 A IL 15987602A IL 15987602 A IL15987602 A IL 15987602A IL 159876 A0 IL159876 A0 IL 159876A0
Authority
IL
Israel
Prior art keywords
drug delivery
delivery systems
release rates
controlled drug
systems providing
Prior art date
Application number
IL15987602A
Other languages
English (en)
Original Assignee
Phoqus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Pharmaceuticals Ltd filed Critical Phoqus Pharmaceuticals Ltd
Publication of IL159876A0 publication Critical patent/IL159876A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15987602A 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates IL159876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117618.9A GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form
PCT/GB2002/003286 WO2003007919A1 (fr) 2001-07-19 2002-07-18 Systemes d'administration controlee de medicaments offrant des taux de liberation variables

Publications (1)

Publication Number Publication Date
IL159876A0 true IL159876A0 (en) 2004-06-20

Family

ID=9918808

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15987602A IL159876A0 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates

Country Status (14)

Country Link
US (1) US20060099257A1 (fr)
EP (1) EP1406597A1 (fr)
JP (2) JP2005519858A (fr)
KR (1) KR20040032857A (fr)
CN (1) CN1556697A (fr)
AU (1) AU2002317360B2 (fr)
BR (1) BR0211156A (fr)
CA (1) CA2457308A1 (fr)
GB (1) GB0117618D0 (fr)
IL (1) IL159876A0 (fr)
MX (1) MXPA04000544A (fr)
RU (1) RU2004104950A (fr)
WO (1) WO2003007919A1 (fr)
ZA (1) ZA200401216B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487417A4 (fr) 2001-09-17 2010-03-17 Glaxo Group Ltd Formulations de medicament en poudre seche
AR045330A1 (es) * 2003-08-07 2005-10-26 Sb Pharmco Inc Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla
US8153159B2 (en) 2003-09-18 2012-04-10 Cephalon, Inc. Modafinil modified release pharmaceutical compositions
WO2005030181A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Preparations a liberation regulee a base d'analgesiques opioides et non opioides
KR20060115860A (ko) * 2003-09-26 2006-11-10 알자 코포레이션 활성 제제의 서방성 전달을 위한 ｏｒｏｓ 푸시-스틱
WO2005030182A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Formulations a liberation commandee presentant un taux croisssant de liberation
WO2005072079A2 (fr) * 2003-09-26 2005-08-11 Alza Coporation Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
ATE401868T1 (de) * 2004-08-04 2008-08-15 Alza Corp ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
DK1836665T3 (da) 2004-11-19 2013-04-15 Glaxosmithkline Llc Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
EP2465500A1 (fr) 2006-05-16 2012-06-20 Knopp Neurosciences, Inc. Quantités thérapeutiquement efficaces de R(+) et S(-) pramipexole pour une utilisation dans le traitement de la maladie de Parkinson
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
WO2008113056A2 (fr) 2007-03-14 2008-09-18 Knopp Neurosciences, Inc. Synthèse de benzothiazole diamines substituées et purifiées du point de vue chiral
JP2011512349A (ja) * 2008-02-15 2011-04-21 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 経口放出制御錠剤
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
US8343524B2 (en) 2008-07-31 2013-01-01 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
US20110142905A1 (en) * 2008-08-14 2011-06-16 Bioneer A/S Coated tablets with remaining degradation surface over the time
EP2334185A4 (fr) * 2008-08-19 2011-09-21 Knopp Neurosciences Inc Compositions et procédés employant du (r)-pramipexole
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
MX2011013577A (es) * 2009-06-19 2012-04-10 Knopp Neurosciences Inc Composiciones y metodos para tratar esclerosis lateral amiotrofica.
WO2011122524A1 (fr) 2010-03-29 2011-10-06 アステラス製薬株式会社 Composition pharmaceutique à libération contrôlée
EP2481411A1 (fr) * 2011-01-27 2012-08-01 Ratiopharm GmbH Formes galéniques orales pour libération modifiée comportant l'inhibiteur de JAK3 tasocitinib
LT5850B (lt) 2011-08-31 2012-07-25 Česlovas Paplauskas Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams
US9597425B2 (en) * 2011-10-18 2017-03-21 St. Teresa Medical, Inc. Method of forming a hemostatic product
CA2859174C (fr) 2011-12-12 2019-03-05 Orbis Biosciences, Inc. Formulations de particules a liberation prolongee
WO2013096816A1 (fr) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Synthèse améliorée de composés substitués par amine de 4,5,6,7-tétrahydrobenzothiazole
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
PL3019167T3 (pl) 2013-07-12 2021-06-14 Knopp Biosciences Llc Leczenie podwyższonych poziomów eozynofili i/lub bazofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
HUE055850T2 (hu) 2013-08-13 2022-01-28 Knopp Biosciences Llc Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
WO2015117004A1 (fr) * 2014-01-31 2015-08-06 Board Of Regents, The University Of Texas System Procédé de préparation de films
CN115645374B (zh) * 2022-12-25 2024-04-26 山东理工职业学院 一种硫酸沙丁胺醇片的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
HUP9901981A3 (en) * 1995-05-09 2000-06-28 Colorcon Ltd Dartford Powder coating composition for electrostatic coating of pharmaceutical substrates
NL1014915C2 (nl) * 1999-04-13 2001-02-12 Beecham Pharm Pte Ltd Nieuwe behandelingsmethode.

Also Published As

Publication number Publication date
JP2005519858A (ja) 2005-07-07
WO2003007919A1 (fr) 2003-01-30
EP1406597A1 (fr) 2004-04-14
KR20040032857A (ko) 2004-04-17
CN1556697A (zh) 2004-12-22
RU2004104950A (ru) 2005-03-10
MXPA04000544A (es) 2005-06-06
AU2002317360B2 (en) 2006-08-17
ZA200401216B (en) 2005-03-17
US20060099257A1 (en) 2006-05-11
BR0211156A (pt) 2004-08-10
JP2005501039A (ja) 2005-01-13
GB0117618D0 (en) 2001-09-12
CA2457308A1 (fr) 2003-01-30

Similar Documents

Publication Publication Date Title
IL159876A0 (en) Controlled drug delivery systems providing variable release rates
HUP0401438A3 (en) Drug delivery system
HUP0500795A2 (en) Gastric retention controlled drug delivery system
MXPA03009727A (es) SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.
TWI350176B (en) Controlled release delivery system for nasal applications
HK1077523A1 (en) Proliposomal drug delivery system
EP1379291A4 (fr) Systeme integre d'administration de medicaments
GB2421689B (en) Drug delivery system
IL155272A0 (en) Systems for optimized drug delivery
GB0123633D0 (en) Stent delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
IL159875A0 (en) Zero order controlled drug delivery system
PL376169A1 (en) Drug delivery system
EP1411905A4 (fr) Systeme d'administration a liberation prolongee
AU2003288608A8 (en) Controlled release, multiple unit drug delivery systems
GB0103877D0 (en) Novel Drug Delivery system
MXPA03007124A (es) Sistemas para el suministro de farmaco con objetivo anti-tumor.
GB0100115D0 (en) Delivery systems
GB0102725D0 (en) Medical delivery system
AU2002304394A1 (en) Controlled release drug delivery device
AU2002246571A1 (en) Drug delivery systems
GB0115136D0 (en) Drug delivery system
GB0112326D0 (en) Drug delivery system
AUPR567801A0 (en) Delivery controlled systems
AU2002228323A1 (en) Spaced drug delivery system